Recommendations for myeloid-derived suppressor cell nomenclature and characterization standards

Bronte, Vincenzo, Brandau, Sven, Chen, Shu-Hsia, Colombo, Mario P., Frey, Alan B., Greten, Tim F., Mandruzzato, Susanna, Murray, Peter J., Ochoa, Augusto, Ostrand-Rosenberg, Suzanne, Rodriguez, Paulo C., Sica, Antonio, Umansky, Viktor, Vonderheide, Robert H., Gabrilovich, Dmitry I.·2016·Nature Communications

DOI 10.1038/ncomms12150

Cited by (1,003)

Items 601–700 of 1,003

Strategies targeting tumor immune and stromal microenvironment and their clinical relevance
Mengying Hu, Leaf Huang · 2022 · Advanced Drug Delivery Reviews
Exosomes derived from myeloid-derived suppressor cells facilitate castration-resistant prostate cancer progression via S100A9/circMID1/miR-506-3p/MID1
Feng Gao, Qiaoping Xu, Zhe Tang, Nan Zhang, Yasheng Huang, Zhongyi Li, Yuliang Dai, Qiqi Yu, Jingyu Zhu · 2022 · Journal of Translational Medicine
Randomized, Double-Blind, Placebo-Controlled Trial of MUC1 Peptide Vaccine for Prevention of Recurrent Colorectal Adenoma
Robert E. Schoen, Lisa A. Boardman, Marcia Roxana Cruz-Correa, Ajay Kr Bansal, David M. Kastenberg, Chin Hur, Lynda Ann. Dzubinski, Sharon F. Kaufman, Luz M. Rodriguez, Ellen S. Richmond et al. · 2023 · Clinical Cancer Research
Neutrophil count is associated with myeloid derived suppressor cell level and presents prognostic value for hepatocellular carcinoma patients
Xing Li, Yan‐Fang Xing, Aihua Lei, Qiang Xiao, Zhi‐Huan Lin, Ying‐Fen Hong, Xiangyuan Wu, Jie Zhou · 2017 · Oncotarget
CD3xPDL1 bi-specific T cell engager (BiTE) simultaneously activates T cells and NKT cells, kills PDL1+ tumor cells, and extends the survival of tumor-bearing humanized mice
Lucas A. Horn, Nicholas G. Ciavattone, Ryan S. Atkinson, Netsanet Woldergerima, Julia Wolf, Virginia K. Clements, Pratima Sinha, Munanchu Poudel, Suzanne Ostrand‐Rosenberg · 2017 · Oncotarget
Immuno-oncology-101: overview of major concepts and translational perspectives
Bertrand Allard, Sandrine Aspeslagh, Soizic Garaud, Floriane Dupont, Cinzia Solinas, Marleen Kok, Bertrand Routy, Christos P. Sotiriou, John Stagg, Laurence Buisseret · 2018 · Seminars in Cancer Biology
Immunosuppressive Role of Myeloid-Derived Suppressor Cells and Therapeutic Targeting in Lung Cancer
Jie Ma, Huaxi Xu, Shengjun Wang · 2018 · Journal of Immunology Research
Role of the RAB7 Protein in Tumor Progression and Cisplatin Chemoresistance
Flora Guerra, Cecilia Bucci · 2019 · Cancers
Myelopoiesis, metabolism and therapy: a crucial crossroads in cancer progression
Antonio Sica, Valentina Guarneri, Alessandra Gennari · 2019 · Cell Stress
Comprehensive Immune Profiling of Medullary Thyroid Cancer
Nikita V. Pozdeyev, Timothy A. Erickson, Lian Zhang, Kim E. Ellison, Christopher J. Rivard, Sharon B. Sams, Fred R. Hirsch, Bryan R. Haugen, Jena D. French · 2020 · Thyroid
Myeloid-Derived Suppressor Cells in Pregnancy and the Neonatal Period
Natascha Köstlin‐Gille, Christian Gille · 2020 · Frontiers in Immunology
Turning enemies into allies—reprogramming tumor-associated macrophages for cancer therapy
Martina Molgora, Marco Colonna · 2021 · Med
A Novel Single Cell RNA-seq Analysis of Non-Myeloid Circulating Cells in Late Sepsis
Dijoia B. Darden, Xiaoru Dong, Maigan Brusko, Lauren S. Kelly, Brittany P. Fenner, Jaimar C. Rincon, Marvin L. S. Dirain, Ricardo F. Ungaro, Dina C. Nacionales, Marie Gauthier et al. · 2021 · Frontiers in Immunology
Polymorphonuclear Myeloid-Derived Suppressor Cells Are Abundant in Peripheral Blood of Cancer Patients and Suppress Natural Killer Cell Anti-Tumor Activity
Nicola Tumino, Francesca Besi, Stefania Martini, Anna Laura Di Pace, Enrico Munari, Linda Quatrini, Andrea Pelosi, Piera Filomena Fiore, Giulia Fiscon, Paola Paci et al. · 2022 · Frontiers in Immunology
Inflammation, Immune Senescence, and Dysregulated Immune Regulation in the Elderly
Carey L. Shive, Pushpa Pandiyan · 2022 · Frontiers in Aging
A Novel DNA Aptamer for Dual Targeting of Polymorphonuclear Myeloid-derived Suppressor Cells and Tumor Cells
Haoran Liu, Junhua Mai, Jianliang Shen, Joy Wolfram, Zhaoqi Li, Guodong Zhang, Rong Xu, Yan Li, Chaofeng Mu, Youli Zu et al. · 2017 · Theranostics
Heterogeneity of Ly6G+Ly6C+Myeloid-Derived Suppressor Cell Infiltrates during Staphylococcus aureus Biofilm Infection
Cortney E. Heim, Sean C. West, Hesham Ali, Tammy Kielian · 2018 · Infection and Immunity
Antibiotic Perturbation of Gut Microbiota Dysregulates Osteoimmune Cross Talk in Postpubertal Skeletal Development
Jessica D. Hathaway‐Schrader, Heidi M. Steinkamp, Michael B. Chavez, Nicole A. Poulides, Joy E. Kirkpatrick, Michael E. Chew, Emily Huang, Alexander V. Alekseyenko, Jose Ignacio Aguirre, Chad M. Novince · 2019 · American Journal Of Pathology
Myeloid-derived suppressor cells impede T cell functionality and promote Th17 differentiation in oral squamous cell carcinoma
Asif Amin Dar, Rushikesh Sudam Patil, Trupti N. Pradhan, Devendra A. Chaukar, Anil Keith Dcruz, Shubhada Vivek Chiplunkar · 2020 · Cancer Immunology Immunotherapy
Myeloid-derived suppressor cell subtypes differentially influence T-cell function, T-helper subset differentiation, and clinical course in CLL
Gerardo Ferrer, Byeongho Jung, Pui Yan Chiu, Rukhsana Aslam, Florencia Palacios, Andrea Nicola Mazzarello, Stefano Vergani, Davide Bagnara, Shih‐Shih Chen, Sophia Yancopoulos et al. · 2021 · Leukemia
Pulmonary toxicants and fibrosis: innate and adaptive immune mechanisms
Rama Malaviya, Howard M. Kipen, Rita Businaro, Jeffrey D. Laskin, Debra L. Laskin · 2020 · Toxicology and Applied Pharmacology
TANK-Binding Kinase 1 (TBK1) Serves as a Potential Target for Hepatocellular Carcinoma by Enhancing Tumor Immune Infiltration
Yuchuan Jiang, Siliang Chen, Qiang Li, Junjie Liang, Weida Lin, Jinying Li, Zhilong Liu, Mingbo Wen, Mingrong Cao, Jian Hong · 2021 · Frontiers in Immunology
Immune landscape after allo-HSCT: TIGIT- and CD161-expressing CD4 T cells are associated with subsequent leukemia relapse
Viviane Gournay, Nicolas Vallet, Vivien Peux, Kristi Vera, Jennifer Bordenave, Marion Lambert, Aurélien Corneau, David Michonneau, Régis Peffault de Latour, Sophie Caillat‐Zucman et al. · 2022 · Blood
Targeting tumour-reprogrammed myeloid cells: the new battleground in cancer immunotherapy
Francesco De Sanctis, Annalisa Adamo, Stefania Canè, Stefano Ugel · 2022 · Seminars in Immunopathology
Pancreatic melatonin enhances anti-tumor immunity in pancreatic adenocarcinoma through regulating tumor-associated neutrophils infiltration and NETosis
Yau-Tuen Chan, Hor‐Yue Tan, Yuanjun Lu, Cheng Zhang, Chien‐shan Cheng, Junyu Wu, Ning Wang, Yibin Feng · 2023 · Acta Pharmaceutica Sinica B
SIRT7 orchestrates melanoma progression by simultaneously promoting cell survival and immune evasion via UPR activation
Xiuli Yi, Huina Wang, Yuqi Yang, Hao Wang, Hengxiang Zhang, Sen Guo, Jianru Chen, Juan Du, Yangzi Tian, Jingjing Ma et al. · 2023 · Signal Transduction and Targeted Therapy
ROS regulation in gliomas: implications for treatment strategies
Yu-Chen Yang, Yu Zhu, Si-Jia Sun, Can-Jun Zhao, Yang Bai, Jin Wang, Litian Ma · 2023 · Frontiers in Immunology
Converting “cold” to “hot”: epigenetics strategies to improve immune therapy effect by regulating tumor‐associated immune suppressive cells
Yijia Tang, Guangzu Cui, Haicong Liu, Ying Han, Changjing Cai, Ziyang Feng, Hong Shen, Shan Zeng · 2024 · 癌症：英文版
The clinical evidence for targeting human myeloid-derived suppressor cells in cancer patients
Richard P. Tobin, Dana M. Davis, Kimberly Rae Jordan, Martin D. McCarter · 2017 · Journal of Leukocyte Biology
Tumor-Derived GM-CSF Promotes Granulocyte Immunosuppression in Mesothelioma Patients
Swati Khanna, Suzanne Graef, Francis Mussai, Anish Thomas, Neha Wali, Bahar Guliz Yenidunya, Constance M. Yuan, Betsy Morrow, Jingli Zhang, Firouzeh Korangy et al. · 2018 · Clinical Cancer Research
Nrf2 Is a Central Regulator of Metabolic Reprogramming of Myeloid-Derived Suppressor Cells in Steady State and Sepsis
Kim Ohl, Athanassios Fragoulis, Patricia Klemm, Julian Baumeister, Wiebke Klock, Eva Verjans, Svenja Böll, Julia Möllmann, Michael Lehrke, Ivan G. Costa et al. · 2018 · Frontiers in Immunology
Repolarization of myeloid derived suppressor cells via magnetic nanoparticles to promote radiotherapy for glioma treatment
Congyu Wu, Megan E. Muroski, Jason M. Miska, Catalina Lee-Chang, Yajing Shen, Aida Rashidi, Peng Zhang, Ting Xiao, Yu Han, Aurora Lopez‐Rosas et al. · 2018 · Nanomedicine Nanotechnology Biology and Medicine
Main Inflammatory Cells and Potentials of Anti-Inflammatory Agents in Prostate Cancer
Takuji Hayashi, Kazutoshi Fujita, Makoto Matsushita, Norio Nonomura · 2019 · Cancers
Context-Dependent Pharmacological Effects of Metformin on the Immune System
Fabrizio Marcucci, Elisabetta Lucia Romeo, Carmelo Antonio Caserta, Cristiano Rumio, François Lefoulon · 2020 · Trends in Pharmacological Sciences
The hypoxic tumour microenvironment: A safe haven for immunosuppressive cells and a therapeutic barrier to overcome
Wai Hoong Chang, Alvina Grace Lai · 2020 · Cancer Letters
Granulocytic Myeloid-Derived Suppressor Cells as Negative Regulators of Anticancer Immunity
Elliot D. Kramer, Scott I. Abrams · 2020 · Frontiers in Immunology
Metabolism of Innate Immune Cells in Cancer
Ronan Talty, Kelly L. Olino · 2021 · Cancers
Tumor-associated hematopoietic stem and progenitor cells positively linked to glioblastoma progression
I‐Na Lu, Celia Dobersalske, Laurèl Rauschenbach, Sarah Teuber‐Hanselmann, Anita Steinbach, Vivien Ullrich, Shruthi Prasad, Tobias Blau, Sied Kebir, Jens Thomas Siveke et al. · 2021 · Nature Communications
Therapeutic Manipulation of Tumor-associated Macrophages: Facts and Hopes from a Clinical and Translational Perspective
Paola Allavena, Clément Anfray, Aldo Ummarino, Fernando Torres · 2021 · Clinical Cancer Research
Neutrophils: Driving inflammation during the development of hepatocellular carcinoma
Hong Chen, Xing-Hao Zhou, Jingru Li, Tang‐Hui Zheng, Fei-Bai Yao, Bo Gao, Tong‐Chun Xue · 2021 · Cancer Letters
FFAR2 expressing myeloid-derived suppressor cells drive cancer immunoevasion
Zeda Zhao, Juliang Qin, Ying Qian, Chenshen Huang, Xiaohong Liu, Ning Wang, Liqin Li, Yuqing Chao, Binghe Tan, Na Zhang et al. · 2024 · Journal of Hematology & Oncology
Patterns of immune evasion in triple-negative breast cancer and new potential therapeutic targets: a review
Lucía Serrano-García, Beatriz Jávega, Antonio Llombart‐Cussac, María Gión, José Manuel Pérez-García, Javier Cortés, María Leonor Fernández-Murga · 2024 · Frontiers in Immunology
Tuning cancer fate: the unremitting role of host immunity
Bianca Calì, Barbara Molon, Antonella Viola · 2017 · Open Biology
Levels of peripheral blood polymorphonuclear myeloid-derived suppressor cells and selected cytokines are potentially prognostic of disease progression for patients with non-small cell lung cancer
Lourdes Barrera, Edgar Montes-Servín, Juan‐Manuel Hernandez‐Martinez, Mario Orozco‐Morales, Elizabeth Montes-Servín, David Michel-Tello, Renato Augusto Morales-Flores, Diana Flores‐Estrada, Oscar G. Arrieta · 2018 · Cancer Immunology Immunotherapy
AMPK Alpha-1 Intrinsically Regulates the Function and Differentiation of Tumor Myeloid-Derived Suppressor Cells
Jimena Trillo-Tinoco, Rosa A. Sierra, Eslam T. Mohamed, Yu Wen Cao, Álvaro de Mingo Pulido, Danielle L. Gilvary, Carmen M. Anadon, Tara Lee Costich, Sheng Wei, Elsa Renee Flores et al. · 2019 · Cancer Research
Trabectedin Reveals a Strategy of Immunomodulation in Chronic Lymphocytic Leukemia
Priyanka Banerjee, Ronghua Zhang, Cristina Ivan, Giovanni Galletti, Karen Clise-Dwyer, Federica Barbaglio, Lydia Scarfò, Miguel Aracil, Christian Klein, William G. Wierda et al. · 2019 · Cancer Immunology Research
The emerging role of myeloid-derived suppressor cells in radiotherapy
Changhee Kang, Seong‐Yun Jeong, Si Yeol Song, Eun Kyung Choi · 2020 · Radiation Oncology Journal
Double-crosser of the Immune System: Macrophages in Tumor Progression and Metastasis
Manzoor Ahmad Mir, Umar Mehraj · 2019 · Current Immunology Reviews
Green propolis increases myeloid suppressor cells and CD4+Foxp3+ cells and reduces Th2 inflammation in the lungs after allergen exposure
Annie Rocio Piñeros, Mikhael Haruo Fernandes de Lima, Tamara Silva Rodrigues, Ana Flávia Gembre, Thaís B. Bertolini, Miriam M. Fonseca, Andresa Aparecida Berretta, Leandra Náira Zambelli Ramalho, Fernando Q. Cunha, Juliana Issa Hori et al. · 2019 · Journal of Ethnopharmacology
Exploiting bone niches: progression of disseminated tumor cells to metastasis
Aaron M. Muscarella, Sergio Aguirre, Xiaoxin Hao, Sarah M. Waldvogel, Xiang H.-F. Zhang · 2021 · Journal of Clinical Investigation
Breast cancer microenvironment and obesity: challenges for therapy
Lauren E. Hillers‐Ziemer, Genevra M. Kuziel, Abbey E. Williams, Brittney N. Moore, Lisa M. Arendt · 2022 · Cancer and Metastasis Reviews
Immune cellular components and signaling pathways in the tumor microenvironment
Sasitorn Yenyuwadee, Konstantinos Aliazis, Qi Wang, Anthos Christofides, Rushil Shah, Nikolaos Patsoukis, Vassiliki A. Boussiotis · 2022 · Seminars in Cancer Biology
Fucoidan, as an immunostimulator promotes M1 macrophage differentiation and enhances the chemotherapeutic sensitivity of capecitabine in colon cancer
Zhenzhen Deng, Ning Wu, Qishan Suo, Jing Wang, Yue Yang, Lihua Geng, Quanbin Zhang · 2022 · International Journal of Biological Macromolecules
Endoplasmic reticulum stress mediates the myeloid-derived immune suppression associated with cancer and infectious disease
Xiaoli Lou, De‐Yong Gao, Liyuan Yang, Yue Wang, Yanqiang Hou · 2023 · Journal of Translational Medicine
Radiation Therapy and Myeloid-Derived Suppressor Cells: Breaking Down Their Cancerous Partnership
Kyra Boorsma Bergerud, Matthew Berkseth, Drew M. Pardoll, Sudipto Ganguly, Lawrence Richard Kleinberg, Jessica Lawrence, David J. Odde, David A. Largaespada, Stephanie Alicia Terezakis, Lindsey Sloan · 2023 · International Journal of Radiation Oncology*Biology*Physics
The characteristics of the tumor immune microenvironment in colorectal cancer with different MSI status and current therapeutic strategies
Qingzhe Wang, Min Yu, Shuang Zhang · 2025 · Frontiers in Immunology
Glycosylation-driven programs coordinate immunoregulatory and pro-angiogenic functions of myeloid-derived suppressor cells
Ada Gabriela Blidner, Camila Agustina Bach, Pablo A. García, Joaquin Pedro Merlo, Alejandro J. Cagnoni, Nadia Bannoud, Montana N Manselle Cocco, Juan M. Pérez‐Sáez, Nicolás A. Pinto, Nicolás I. Torres et al. · 2025 · Immunity
HIF-1α is a key regulator in potentiating suppressor activity and limiting the microbicidal capacity of MDSC-like cells during visceral leishmaniasis
Akil Hammami, Belma Melda Abidin, Tania Charpentier, Aymeric Fabié, Annie-Pier Duguay, Krista M. Heinonen, Simona Stäger · 2017 · PLoS Pathogens
Induction of immunosuppressive functions and NF-κB by FLIP in monocytes
Alessandra Fiore, Stefano Ugel, Francesco De Sanctis, Sara Sandri, Giulio Fracasso, Rosalinda Trovato, Silvia Sartoris, Samantha Solito, Susanna Mandruzzato, Fulvia Vascotto et al. · 2018 · Nature Communications
Early myeloid-derived suppressor cells (HLA-DR−/lowCD33+CD16−) expanded by granulocyte colony-stimulating factor prevent acute graft-versus-host disease (GVHD) in humanized mouse and might contribute to lower GVHD in patients post allo-HSCT
Ke Wang, Meng Lv, Ying‐Jun Chang, Xiaosu Zhao, Xiao‐Su Zhao, Yuanyuan Zhang, Yuqian Sun, Zhidong Wang, Pan Suo, Yang Zhou et al. · 2019 · Journal of Hematology & Oncology
Docosahexaenoic acid inhibits both NLRP3 inflammasome assembly and JNK-mediated mature IL-1β secretion in 5-fluorouracil-treated MDSC: implication in cancer treatment
Adélie Dumont, Charlotte de Rosny, Trinh‐Le‐Vi Kieu, Sabrina Perrey, Hélène Berger, Aurélie Fluckiger, Tania Muller, Jean-Paul Paı̈s de Barros, Laurent Pichon, Aziz Hichami et al. · 2019 · Cell Death and Disease
Neutrophils as Suppressors of T Cell Proliferation: Does Age Matter?
Cathelijn E.M. Aarts, Ida H. Hiemstra, Anton T. J. Tool, Timo K. van den Berg, Erik P. J. Mul, Robin van Bruggen, Taco Willem Kuijpers · 2019 · Frontiers in Immunology
Ovarian cancer modulates the immunosuppressive function of CD11b+Gr1+ myeloid cells via glutamine metabolism
Mary Priyanka Udumula, Sharif Sakr, Sajad Ahmad Dar, Ayesha B. Alvero, Rouba Ali‐Fehmi, Eman Abdulfatah, Jing Li, Jun Jiang, Amy Tang, Thomas Buekers et al. · 2021 · Molecular Metabolism
Extracellular vesicles in anti-tumor immunity
Elisabetta Vergani, Elena Daveri, Viviana Vallacchi, Laura Bergamaschi, Luca Lalli, Chiara Castelli, Monica Rodolfo, Licia Rivoltini, Veronica Huber · 2021 · Seminars in Cancer Biology
Polysaccharide-rich extract from Polygonatum sibiricum protects hematopoiesis in bone marrow suppressed by triple negative breast cancer
Ying Xie, Ziwei Jiang, Rui Yang, Yiyi Ye, Lixia Pei, Si Xiong, Shunchun Wang, Lisheng Wang, Sheng Liu · 2021 · Biomedicine & Pharmacotherapy
Cancer cell-derived type I interferons instruct tumor monocyte polarization
Dylan Kwart, Jing He, Subhashini Srivatsan, Clarissa Lett, Jacquelynn Golubov, Erin M. Oswald, Patrick Poon, Xuan Ye, Janelle C. Waite, Arielle Glatman Zaretsky et al. · 2022 · Cell Reports
The human placenta shapes the phenotype of decidual macrophages
Sigrid Vondra, Anna-Lena Höbler, Andreas Ian Lackner, Johanna Raffetseder, Zala Nikita Mihalič, Andrea Vogel, Leila Saleh, Victoria Kunihs, Peter Haslinger, Markus Wahrmann et al. · 2023 · Cell Reports
Preoperative systemic inflammatory response index predicts the prognosis of patients with hepatocellular carcinoma after liver transplantation
Songping Cui, Shuang Cao, Qing Chen, Qiang He, Ren Lang · 2023 · Frontiers in Immunology
Unraveling resistance to immunotherapy in MSI-high colorectal cancer
Heregger, Ronald, Huemer, Florian, Steiner, Markus, Gonzalez-Martinez, Alejandra, Greil, Richard, Weiss, Lukas · 2023 · Cancers
The Role of Myeloid-Derived Suppressor Cells in Viral Infection
Megan A. O’Connor, Jessica L. Rastad, William R. Green · 2017 · Viral Immunology
Targeting the CXCL12/CXCR4 pathway and myeloid cells to improve radiation treatment of locally advanced cervical cancer
Magali Lecavalier‐Barsoum, Naz Chaudary, Kathy Chai-Zung Han, Marianne Koritzinsky, Richard Peter Hill, Michael Milosevic · 2018 · International Journal of Cancer
Analysis of the Trichuris suis excretory/secretory proteins as a function of life cycle stage and their immunomodulatory properties
Louis‐Philippe Leroux, Mohamad Nasr, Rajesh M. Valanparambil, Mifong Tam, Bruce A. Rosa, E A Siciliani, Dolores E. Hill, Dante S. Zarlenga, Maritza Jaramillo, Joel V. Weinstock et al. · 2018 · Scientific Reports
The Emerging Role of Myeloid-Derived Suppressor Cells in Tuberculosis
Tandeka Magcwebeba, Anca Dorhoi, Nelita du Plessis · 2019 · Frontiers in Immunology
CD244 represents a new therapeutic target in head and neck squamous cell carcinoma
Laura Agresta, Maria A. Lehn, Kristin Lampe, Rachel Cantrell, Cassandra M. Hennies, Sara Szabo, Trisha Michel Wise-Draper, Laura Conforti, Kasper H. N. Hoebe, Edith M. Janssen · 2020 · Journal for ImmunoTherapy of Cancer
Selective targeting of different populations of myeloid-derived suppressor cells by histone deacetylase inhibitors
Ayumi Hashimoto, Takeshi Fukumoto, Rugang Zhang, Dmitry I. Gabrilovich · 2020 · Cancer Immunology Immunotherapy
pH-Channeling in Cancer: How pH-Dependence of Cation Channels Shapes Cancer Pathophysiology
Zoltán Pethő, Karolina Najder, Tiago M. A. Carvalho, Roisin McMorrow, Luca Matteo Todesca, Micol Rugi, Etmar Bulk, Alan B. Chan, Clemens W.G.M. Löwik, Stephan J. Reshkin et al. · 2020 · Cancers
Galectin-3 inhibition with belapectin combined with anti-OX40 therapy reprograms the tumor microenvironment to favor anti-tumor immunity
Elizabeth R. Sturgill, Annah S. Rolig, Stefanie N. Linch, Courtney Mick, Melissa J. Kasiewicz, Zhaoyu Sun, Peter G. Traber, Harold H. Shlevin, William L. Redmond · 2021 · OncoImmunology
Modulating tumor infiltrating myeloid cells to enhance bispecific antibody-driven T cell infiltration and anti-tumor response
Jeong Ah Park, Linlin Wang, Nai‐Kong V. Cheung · 2021 · Journal of Hematology & Oncology
Dual G9A/EZH2 Inhibition Stimulates Antitumor Immune Response in Ovarian High-Grade Serous Carcinoma
Pavlina Spiliopoulou, Sarah Spear, Hasan Mirza, Ian Garner, Lynn McGarry, Fabio Grundland-Freile, Zhao Cheng, Darren P. Ennis, Nayana Iyer, Sophie McNamara et al. · 2022 · Molecular Cancer Therapeutics
Small extracellular vesicles induce resistance to anti-GD2 immunotherapy unveiling tipifarnib as an adjunct to neuroblastoma immunotherapy
Xiaoming Liu, Carson A. Wills, Longgui Chen, Jiawen Zhang, Yuanjun Zhao, Mi Zhou, Jeffrey M. Sundstrom, Todd D. Schell, Vladimir S. Spiegelman, Megan M. Young et al. · 2022 · Journal for ImmunoTherapy of Cancer
MDSCs in breast cancer: an important enabler of tumor progression and an emerging therapeutic target
Haoyu Liu, Zhicheng Wang, Zhou Yuntao, Yuan‐Han Yang · 2023 · Frontiers in Immunology
Sialic acid blockade inhibits the metastatic spread of prostate cancer to bone
Kirsty Hodgson, Margarita Orozco‐Moreno, Emily Archer Goode, Matthew Fisher, Rebecca Garnham, Richard Beatson, Helen Turner, Karen E. Livermore, Yuhan Zhou, Laura Wilson et al. · 2024 · EBioMedicine
Immune biomarkers for chronic inflammation related complications in non-cancerous and cancerous diseases
Yaron Meirow, Michal Baniyash · 2017 · Cancer Immunology Immunotherapy
Notch Signaling in Myeloid Cells as a Regulator of Tumor Immune Responses
Fokhrul M. Hossain, Samarpan Majumder, Deniz A. Uçar, Paulo C. Rodrı́guez, Todd Eliot Golde, Lisa M. Minter, Barbara A. Osborne, Lucio Miele · 2018 · Frontiers in Immunology
TLR1/TLR2 signaling blocks the suppression of monocytic myeloid-derived suppressor cell by promoting its differentiation into M1-type macrophage
Yuting Deng, Jiao Yang, Jiawen Qian, Ronghua Liu, Enyu Huang, Yuedi Wang, Feifei Luo, Yiwei Chu · 2019 · Molecular Immunology
Driving Immune Responses in the Ovarian Tumor Microenvironment
Franklin Ning, Christopher B. Cole, Christina M. Annunziata · 2021 · Frontiers in Oncology
Breast Cancer Drug Resistance: Overcoming the Challenge by Capitalizing on MicroRNA and Tumor Microenvironment Interplay
Giulia Cosentino, Ilaria Plantamura, Elda Tagliabue, Marilena Valeria Iorio, Alessandra Cataldo · 2021 · Cancers
Neuroblastoma Formation Requires Unconventional CD4 T Cells and Arginase-1–Dependent Myeloid Cells
Lee-Ann Van de Velde, Emma Kaitlynn Allen, Jeremy Chase Crawford, Taylor Leigh Wilson, Clifford S. Guy, Marion Russier, Leonie Zeitler, Armita Bahrami, David Finkelstein, S. William Pelletier et al. · 2021 · Cancer Research
Interleukin-37 promotes colitis-associated carcinogenesis via SIGIRR-mediated cytotoxic T cells dysfunction
Zhen Wang, Fanlian Zeng, Yawen Hu, Xiaoyan Wang, Fulei Zhao, Pei Zhou, Jing Hu, Yuanyuan Xiao, Zhonglan Hu, Mingfeng Guo et al. · 2022 · Signal Transduction and Targeted Therapy
Fatty Acid Metabolism and Cancer Immunotherapy
Yuting Luo, Hanbing Wang, Baorui Liu, Jia Wei · 2022 · Current Oncology Reports
Challenges to the broad application of allogeneic natural killer cell immunotherapy of cancer
Philippa R Kennedy, Martin Felices, Jeffrey S. Miller · 2022 · Stem Cell Research & Therapy
Bone Microenvironment-Suppressed T Cells Increase Osteoclast Formation and Osteolytic Bone Metastases in Mice
Danna L. Arellano, Patricia Juárez, Andrea Verdugo‐Meza, Paloma S. Almeida‐Luna, Juan A. Corral‐Avila, Florian Drescher, Felipe Olvera, Samanta Jiménez, Bennett D. Elzey, Theresa A. Guise et al. · 2020 · Journal of Bone and Mineral Research
Tissue Site and the Cancer Immunity Cycle
Brendan L. Horton, Tim B. Fessenden, Stefani Spranger · 2019 · Trends in cancer
Myeloid Cell Modulation by Tumor-Derived Extracellular Vesicles
Ihor Arkhypov, Samantha Lasser, Vera Petrova, Rebekka Weber, Christopher Groth, Jochen Sven Utikal, Peter Altevogt, Viktor Umansky · 2020 · International Journal of Molecular Sciences
Sympathetic nervous tone limits the development of myeloid-derived suppressor cells
James Timothy Nevin, Marmar R. Moussa, William L. Corwin, Ion Măndoiu, Pramod Kumar Srivastava · 2020 · Science Immunology
Emerging Canonical and Non-Canonical Roles of Granzyme B in Health and Disease
Ellis J Tibbs, Xuefang Cao · 2022 · Cancers
Epigenetic remodeling of the immune landscape in cancer: therapeutic hurdles and opportunities
Feng‐Ming Tien, Hsuan‐Hsuan Lu, Shu‐Yung Lin, Hsing-Chen Tsai · 2023 · Journal of Biomedical Science
Insights into CSF-1R Expression in the Tumor Microenvironment
Caterina Tomassetti, Gaia Insinga, Francesca Gimigliano, Andrea Morrione, Antonio Giordano, Emanuele Giurisato · 2024 · Biomedicines
Histidine decarboxylase (HDC)-expressing granulocytic myeloid cells induce and recruit Foxp3+ regulatory T cells in murine colon cancer
Xiaowei Chen, Yoshihiro Takemoto, Huan Deng, Moritz A. Middelhoff, Richard A. Friedman, Timothy H. Chu, Michael Churchill, Yan Ma, Karan K. Nagar, Yagnesh H. Tailor et al. · 2017 · OncoImmunology
Immunomodulatory effects of myeloid-derived suppressor cells in diseases: Role in cancer and infections
Ruth S. E. Tamadaho, Achim M. Hoerauf, Laura E. Layland · 2017 · Immunobiology